Clay Northam Wealth Management, LLC Ardelyx, Inc. Transaction History
Clay Northam Wealth Management, LLC
- $152 Million
- Q4 2024
A detailed history of Clay Northam Wealth Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Clay Northam Wealth Management, LLC holds 307,680 shares of ARDX stock, worth $1.52 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
307,680
Previous 281,472
9.31%
Holding current value
$1.52 Million
Previous $1.94 Million
18.0%
% of portfolio
1.04%
Previous 1.35%
Shares
5 transactions
Others Institutions Holding ARDX
# of Institutions
231Shares Held
150MCall Options Held
1.54MPut Options Held
3.08M-
Janus Henderson Group PLC London, X024.4MShares$120 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$86.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.4MShares$70.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.6MShares$57.2 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C310.3MShares$51 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $762M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...